Sokratis Stoumpos, Kirsty Crowe, Pantelis Sarafidis, Jonathan Barratt, Davide Bolignano, Lucia Del Vecchio, Jolanta Małyszko, Andrzej Więcek, Alberto Ortiz, Mario Cozzolino
Anaemia is a common complication of chronic kidney disease (CKD) and is associated with poor long-term outcomes and quality of life. The use of supplemental iron, erythropoiesis stimulating agents (ESAs) and blood transfusions has been the mainstay of treatment of anaemia in CKD for more than three decades. Despite available treatments, CKD patients with anaemia are undertreated and moderate-to-severe anaemia remains prevalent in the CKD population. Anaemia has consistently been associated with greater mortality, hospitalisation, cardiovascular events, and CKD progression in patients with CKD, and the risk increases with anaemia severity...
April 4, 2024: Nephrology, Dialysis, Transplantation